These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25273057)

  • 1. Contribution of glucose to crystallization of phenytoin in injectable dosage form by dilution with infusion fluids.
    Onuki Y; Hasegawa N; Ikegami-Kawai M; Suematsu T; Sakurai S; Shirozu S; Tsubuki M; Obata Y; Takayama K
    Chem Pharm Bull (Tokyo); 2014; 62(10):989-93. PubMed ID: 25273057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5% glucose infusion fluid provokes significant precipitation of phenytoin sodium injection via interruption of the cosolvent effect of propylene glycol.
    Onuki Y; Ikegami-Kawai M; Ishitsuka K; Hayashi Y; Takayama K
    Chem Pharm Bull (Tokyo); 2012; 60(1):86-93. PubMed ID: 22223379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility and pH variability of four injectable phenytoin sodium products.
    Markowsky SJ; Kohls PR; Ehresman D; Leppik I
    Am J Hosp Pharm; 1991 Mar; 48(3):510-4. PubMed ID: 2028998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of phenytoin solubility in intravenous admixtures: physicochemical theory.
    Newton DW; Kluza RB
    Am J Hosp Pharm; 1980 Dec; 37(12):1647-51. PubMed ID: 7446539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal face identification by Raman microscopy for assessment of crystal habit of a drug.
    Moriyama K; Furuno N; Yamakawa N
    Int J Pharm; 2015 Mar; 480(1-2):101-6. PubMed ID: 25615983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization of toxic glycol solvates of rifampin from glycerin and propylene glycol contaminated with ethylene glycol or diethylene glycol.
    de Villiers MM; Caira MR; Li J; Strydom SJ; Bourne SA; Liebenberg W
    Mol Pharm; 2011 Jun; 8(3):877-88. PubMed ID: 21401126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersaturated state of diazepam injection following dilution with infusion fluid.
    Onuki Y; Hasegawa N; Kida C; Ikegami-Kawai M; Tsubuki M; Shirozu S; Obata Y; Takayama K
    J Pharm Health Care Sci; 2015; 1():9. PubMed ID: 26819720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
    Thakur R; Gupta RB
    Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization of three phenytoin preparations in intravenous solutions.
    Giacona N; Bauman JL; Siepler JK
    Am J Hosp Pharm; 1982 Apr; 39(4):630-4. PubMed ID: 7081239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding crystallization of lorazepam during infusion.
    Vellema J; Hunfeld NG; Van den Akker HE; ter Horst JH
    Eur J Pharm Sci; 2011 Dec; 44(5):621-6. PubMed ID: 22024382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coarse-grained modeling of crystal growth and polymorphism of a model pharmaceutical molecule.
    Mandal T; Marson RL; Larson RG
    Soft Matter; 2016 Oct; 12(39):8246-8255. PubMed ID: 27714373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of nitroglycerin in intravenous admixtures.
    Klamerus KJ; Ueda CT; Newton DW
    Am J Hosp Pharm; 1984 Feb; 41(2):303-5. PubMed ID: 6422753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions.
    Muhrer G; Meier U; Fusaro F; Albano S; Mazzotti M
    Int J Pharm; 2006 Feb; 308(1-2):69-83. PubMed ID: 16324806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the crystalline form of phenytoin.
    Chakrabarti S; van Severen R; Braeckman P
    Pharmazie; 1978 Jun; 33(6):338-9. PubMed ID: 684047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of propylene glycol and glycerol infusions as treatments for ketosis in dairy cows.
    Piantoni P; Allen MS
    J Dairy Sci; 2015 Aug; 98(8):5429-39. PubMed ID: 26074245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-level elucidation of saccharin-assisted rapid dissolution and high supersaturation level of drug from Eudragit
    Ueda K; Kanaya H; Higashi K; Yamamoto K; Moribe K
    Int J Pharm; 2018 Mar; 538(1-2):57-64. PubMed ID: 29341907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Injectable phenytoin: problems of stability in solution].
    Francés A; García Martí A; Bruck M
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):9-12. PubMed ID: 9303825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations.
    Baumgartner R; Eitzlmayr A; Matsko N; Tetyczka C; Khinast J; Roblegg E
    Int J Pharm; 2014 Dec; 477(1-2):1-11. PubMed ID: 25304093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Insight into Different Stabilization Mechanisms of Phenytoin Derivatives Supersaturation by HPMC and PVP.
    Otsuka N; Ueda K; Ohyagi N; Shimizu K; Katakawa K; Kumamoto T; Higashi K; Yamamoto K; Moribe K
    J Pharm Sci; 2015 Aug; 104(8):2574-82. PubMed ID: 26059285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.